Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Applewhite and Sherman Respond

Dinah P Applewhite1, Susan G Sherman1

  • 1Dinah P. Applewhite is with the Internal Medicine Program, Massachusetts General Hospital, Boston, MA. Susan G. Sherman is with the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

American Journal of Public Health
|June 8, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Unintentional benzodiazepine use and frequency of drug checking service utilization: a cross-sectional study.

Harm reduction journal·2026
Same author

A qualitative evaluation of the implementation of a statewide drug checking program using the Consolidated Framework for Implementation Research.

Journal of substance use and addiction treatment·2026
Same author

The Drug Market's Impact on the Overdose Risk Environment for Women Who Use Drugs During the COVID-19 Pandemic.

Journal of urban health : bulletin of the New York Academy of Medicine·2026
Same author

Harm reduction vending machines: An opportunity to bridge the resource access gap in non-urban communities.

Health & place·2026
Same author

Identification of distinct stimulant use trajectories and patterns of overdose.

Addictive behaviors reports·2026
Same author

'If you've ever experienced it, you'd feel differently': Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States.

Addiction (Abingdon, England)·2026